Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Commentary

Cortactin overexpression results in sustained epidermal growth factor receptor signaling by preventing ligand-induced receptor degradation in human carcinoma cells

Agnes GSH van Rossum1 email, Johan Gibcus2 email, Jacqueline van der Wal2 email and Ed Schuuring2 email

Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands

Department of Pathology, University Medical Center Groningen, The Netherlands

author email corresponding author email

Breast Cancer Research 2005, 7:235-237doi:10.1186/bcr1316

Published: 25 August 2005

Abstract

The chromosome 11q13 region is frequently amplified in human carcinomas and results in an increased expression of various genes including cortactin, and is also associated with an increased invasive potential. Cortactin acts as an important regulator of the actin cytoskeleton. It is therefore very tempting to speculate that cortactin is the crucial gene within the 11q13 amplicon that mediates the invasive potential of these carcinomas. Cortactin also participates in receptor-mediated endocytosis, and recent findings have shown that, during receptor internalization, cortactin overexpression inhibits the ubiquitylation-mediated degradation of the epidermal growth factor receptor, resulting in a sustained ligand-induced epidermal growth factor receptor activity.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.